PRGO - PERRIGO COMPANY PLC -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
PERRIGO COMPANY PLC
Perrigo Co PLC is a healthcare company providing branded OTC products throughout Europe and the USA. It sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China.
IPO Date: December 17, 1991
Sector: Healthcare
Industry: Pharma
Market Cap: $2.02B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.78 | 1.42%
Avg Daily Range (30 D): $0.35 | 2.46%
Avg Daily Range (90 D): $0.31 | 2.51%
Institutional Daily Volume
Avg Daily Volume: 1.1M
Avg Daily Volume (30 D): 2.15M
Avg Daily Volume (90 D): 2.37M
Trade Size
Avg Trade Size (Sh.): 103
Avg Trade Size (Sh.) (30 D): 84
Avg Trade Size (Sh.) (90 D): 79
Institutional Trades
Total Institutional Trades: 18,011
Avg Institutional Trade: $3.57M
Avg Institutional Trade (30 D): $4.6M
Avg Institutional Trade (90 D): $5.49M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $6.94M
Avg Closing Trade (30 D): $7M
Avg Closing Trade (90 D): $7.94M
Avg Closing Volume: 144.74K
 
News
Aug 22, 2026 @ 9:15 PM
This Under-the-Radar Healthcare Stock Yields Nearl...
Source: Reuben Gregg Brewer
Apr 29, 2026 @ 12:56 PM
Perrigo Announces Quarterly Dividend
Source: Prnewswire
Apr 29, 2026 @ 6:30 AM
3 Healthcare Stocks Paying the Highest Dividends i...
Source: Thomas Niel
Mar 6, 2026 @ 12:36 PM
5 Small Stocks, 5 Super-Sized Payouts of Up To 11%...
Source: Brett Owens
Mar 3, 2026 @ 4:00 PM
Good Start® | Dr. Brown's™ Infant Formula...
Source: Baby Innovation Awards
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-12.52 $.54 $-2.87
Diluted EPS $-12.53 $.53 $-2.87
Revenue $4.14B $1.02B $969.2M
Gross Profit $1.38B $313.9M $325.5M
Net Income / Loss $-1734.7M $74.4M $-398.6M
Operating Income / Loss $-1563.3M $23.5M $-372.3M
Cost of Revenue $2.77B $708.9M $643.7M
Net Cash Flow $-51.7M $43.1M $-171.3M
PE Ratio